1. Paradoxical Modulation of STN β-Band Activity with Medication Compared to Deep Brain Stimulation.
- Author
-
Hill ME, Johnson LA, Wang J, Escobar Sanabria D, Patriat R, Cooper SE, Park MC, Harel N, Vitek JL, and Aman JE
- Subjects
- Humans, Levodopa therapeutic use, Biomarkers, Subthalamic Nucleus physiology, Deep Brain Stimulation, Parkinson Disease
- Abstract
Background: Excessive subthalamic nucleus (STN) β-band (13-35 Hz) synchronized oscillations has garnered interest as a biomarker for characterizing disease state and developing adaptive stimulation systems for Parkinson's disease (PD)., Objectives: To report on a patient with abnormal treatment-responsive modulation in the β-band., Methods: We examined STN local field potentials from an externalized deep brain stimulation (DBS) lead while assessing PD motor signs in four conditions (OFF, MEDS, DBS, and MEDS+DBS)., Results: The patient presented here exhibited a paradoxical increase in β power following administration of levodopa and pramipexole (MEDS), but an attenuation in β power during DBS and MEDS+DBS despite clinical improvement of 50% or greater under all three therapeutic conditions., Conclusions: This case highlights the need for further study on the role of β oscillations in the pathophysiology of PD and the importance of personalized approaches to the development of β or other biomarker-based DBS closed loop algorithms. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society., (© 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.)
- Published
- 2024
- Full Text
- View/download PDF